SCHEMBL13768481

SCHEMBL13768481

Nc1ccc(N)c(NS(=O)(=O)/C=C/c2ccc(Cl)c(Cl)c2)c1

nearest known ligand 0.57

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
PTGES2 Q9H7Z7 17/20 0.57
CYP3A4 P08684 2/20 0.39
TSHR P16473 2/20 0.39
ALDH1A1 P00352 1/20 0.39
THRB P10828 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
CASP1 P29466 1/20 0.39
RECQL P46063 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13062159 0.86 PTGES2 (0.77) PTGES2
SCHEMBL13639450 0.84 PTGES2 (0.52) PTGES2
SCHEMBL3779094 0.74 PTGES2 (0.78) PTGES2
SCHEMBL3782941 0.74 PTGES2 (0.78) PTGES2
SCHEMBL3782945 0.74 PTGES2 (0.78) PTGES2
SCHEMBL3779099 0.74 PTGES2 (0.78) PTGES2
SCHEMBL3785279 0.73 PTGES2 (1.00) PTGES2
SCHEMBL3785282 0.73 PTGES2 (1.00) PTGES2
SCHEMBL3782510 0.73 PTGES2 (1.00) PTGES2
SCHEMBL3775127 0.73 PTGES2 (0.75) PTGES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009082347-A1 BIS- (SULF ONYLAMINO) DERIVATIVES FOR USE IN THERAPY ASTRAZENECA AB (SE) 2009-07-02 WO disclosed